Cargando…
Hybrid polymeric matrices for oral modified release of Desvenlafaxine succinate tablets
Purpose: Desvenlafaxine succinate (DSV) is a water soluble anti-depressant drug, which is rapidly absorbed after oral administration exaggerating its side effects. The current work aimed to prepare controllable release DSV matrix to reduce DSV side effects related to its initial burst. Methods: Fift...
Autores principales: | Samy, Wael, Elnoby, Ayman, El-Gowelli, Hanan M., Elgindy, Nazik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506642/ https://www.ncbi.nlm.nih.gov/pubmed/28725139 http://dx.doi.org/10.1016/j.jsps.2016.10.005 |
Ejemplares similares
-
Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
por: Carapeto, Gustavo Vaiano, et al.
Publicado: (2023) -
Desvenlafaxine
por: Andrade, Chittaranjan
Publicado: (2009) -
Metoprolol succinate extended release/hydrochlorothiazide combination tablets
por: Hainer, James W, et al.
Publicado: (2007) -
Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics
por: Elzoghby, Ahmed O, et al.
Publicado: (2013) -
Precisely Fabricated Sulpiride-Loaded Nanolipospheres with Ameliorated Oral Bioavailability and Antidepressant Activity
por: Mohyeldin, Salma M, et al.
Publicado: (2021)